Respiri (KMLXF) Stock Price, News & Analysis

Company Overview

Respiri (OTCMKTS:KMLXF) is a digital health company specializing in remote monitoring solutions for respiratory conditions, with a focus on asthma management. The company has developed a portable, FDA-cleared device and companion mobile application designed to detect and track wheezing in real time. By integrating acoustic sensors with cloud-enabled analytics, Respiri’s technology aims to provide patients and clinicians with actionable insights to improve asthma control and reduce the risk of exacerbations.

At the core of Respiri’s offering is the Wheezo lung monitoring system, which captures respiratory sounds during normal breathing and analyzes them for indicators of airway obstruction. Users can perform simple home-based tests that upload encrypted data to a secure platform, allowing healthcare providers to monitor trends and intervene early. The system also offers medication reminders and personalised reports, helping patients adhere to treatment plans and empowering clinicians to make data-driven decisions.

Founded in Australia, Respiri operates from its headquarters in Sydney and maintains a presence in the United States. The company secured FDA 510(k) clearance for its wheeze detection technology in 2020 and continues to explore strategic partnerships with healthcare networks and telemedicine providers. Respiri’s solutions are positioned to address the growing demand for telehealth tools that support chronic respiratory care outside of traditional clinical settings.

Respiri’s leadership team brings together expertise in medical device development, regulatory affairs and digital health innovation. Under the guidance of its executive management, the company is advancing clinical validation studies and pursuing broader adoption of its remote monitoring platform among pediatric and adult asthma populations.

Key Stats

• Today's Range: $0.06 to $0.06
• 50-Day Range: $0.06 to $0.06
• 52-Week Range: $0.04 to $0.05
• Volume: N/A
• Average Volume: 6,100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KMLXF Stock Analysis - Frequently Asked Questions

How have KMLXF shares performed this year?

Respiri's stock was trading at $0.0581 at the beginning of 2025. Since then, KMLXF shares have increased by 0.0% and is now trading at $0.0581.

How do I buy shares of Respiri?

Shares of KMLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/19/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private Households
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:KMLXF
• CIK: N/A
• Web: www.respiri.co
• Phone: 61 3 9653 9160
• Fax: 61 -0-3 9602 3606
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.07 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.07